UNSPSC 85671711: Supplement right lower extremity bursa and ligament with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right lower extremity bursa and ligament with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0MUV4JZ

UNSPSC 85671711 Supplement right lower extremity bursa and ligament with synthetic substitute, percutaneous endoscopic approach is a Commodity code that, based on recent state and local procurement activity, does not align with the work actually being solicited under this designation. The recent opportunities tagged to this code cover independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, temporary health professional staffing, surgical benefit carve-outs, and emergency medical services for detained youth — none of which involve orthopedic surgical implants or procedures on the lower extremity. The code appears to describe a specific surgical procedure or device, yet state and local governments are using it to classify administrative healthcare services, medical staffing, and benefit management. This mismatch suggests either a data classification error or a fundamental disconnect between the code's clinical scope and how jurisdictions are tagging their healthcare-related procurements.

The recent opportunities show issuing bodies across multiple states and sectors: the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation (Washington), Harris County Juvenile Probation Department (Texas), Collier County (Florida), and the County of Santa Clara Health System (California). Response dates have ranged from late August through mid-October 2026, with no single jurisdiction appearing more than once. Given the absence of relevant recent activity under the Commodity code's stated scope, firms pursuing lower-extremity orthopedic implants or surgical procedures should not rely on this code classification to identify state and local buying opportunities; the code shows little decision-relevant procurement signal for medical device or surgical-product vendors in the current market.